Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Using credit card points for travel can transform your journeys. Explore our guide to make the most of your points for unforgettable trips.
19,769 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...
As natural gas swings capture traders’ attention, UNG and FCG offer competing paths: near-term futures exposure vs. e...
ServiceNow could deliver durable growth as organizations automate more workflows. This article lays out the bull case...
A major fund boosted its Vicor stake, sending the stock higher as a 200% rally unfolds. This article unpacks the bet,...
New home sales edged lower in December but remain near multiyear highs at 745,000 SAAR, driven by financing incentive...
A key chart indicator is flashing again as Bitcoin eyes potential downside. Analysts warn the three-day death cross c...
Bitcoin is on track for a fifth consecutive monthly decline, driven by ETF outflows and shifting macro sentiment that...
This in-depth guide analyzes agilon health (agl) 2025 implications for investors. Learn the business model, key metri...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Market chatter links the billionaire investor against Nvidia to a new stake in Adobe, potentially signaling a strateg...